Intercept Pharmaceuticals Inc logo

Intercept Pharmaceuticals Inc

NAS:ICPT (USA)  
2
$ 13.69 +0.1 (+0.74%) 11:08 PM EST
P/E:
2.12
P/B:
6.11
Market Cap:
$ 570.46M
Enterprise V:
$ 413.40M
Volume:
624.16K
Avg Vol (2M):
788.78K
Also Trade In:
Volume:
624.16K
Market Cap $:
570.46M
PE Ratio:
2.12
Avg Vol (2M):
788.78K
Enterprise Value $:
413.40M
PB Ratio:
6.11

ICPT Stock Institutional Ownership and Insider Ownership - Intercept Pharmaceuticals Inc

41.67
(Mil)
Shares Outstanding
44.89%
18.59 (Mil)
Institutional Ownership
4.03%
1.67 (Mil)
Insider Ownership
78.52%
32.7203 (Mil)
Float Percentage of TSO

Short Interest History (%)

Due to a license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus’ website, except for certain Australian stocks.

Institutional Ownership History (%)

This the Institutional Ownership History of Intercept Pharmaceuticals Inc. Peter Lynch prefers to buy companies with low institutional ownership.

Insider ownership (%)

This is the historical insider ownership of Intercept Pharmaceuticals Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.

Top Direct Holders

Top Fund Holders